DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $615 | -30.1% | 2,479 | -32.4% | 0.85% | +45.6% |
| Q2 2023 | $880 | -45.1% | 3,666 | -42.4% | 0.58% | -22.0% |
| Q1 2023 | $1,604 | -20.6% | 6,366 | -16.4% | 0.75% | -17.2% |
| Q4 2022 | $2,021 | -99.9% | 7,616 | -25.7% | 0.91% | -4.8% |
| Q3 2022 | $2,648,000 | -5.4% | 10,253 | -7.1% | 0.95% | -2.7% |
| Q2 2022 | $2,798,000 | -13.6% | 11,037 | 0.0% | 0.98% | +3.6% |
| Q1 2022 | $3,237,000 | -10.9% | 11,037 | 0.0% | 0.94% | -4.0% |
| Q4 2021 | $3,631,000 | +37.7% | 11,037 | +27.5% | 0.98% | +9.5% |
| Q3 2021 | $2,636,000 | +66.1% | 8,658 | +46.4% | 0.90% | +44.4% |
| Q2 2021 | $1,587,000 | +19.2% | 5,915 | 0.0% | 0.62% | +10.5% |
| Q1 2021 | $1,331,000 | +8.6% | 5,915 | +7.2% | 0.56% | +9.5% |
| Q4 2020 | $1,226,000 | -16.5% | 5,520 | -19.1% | 0.51% | -24.9% |
| Q3 2020 | $1,469,000 | +21.8% | 6,820 | 0.0% | 0.68% | +11.2% |
| Q2 2020 | $1,206,000 | +27.8% | 6,820 | 0.0% | 0.62% | +31.4% |
| Q1 2020 | $944,000 | -9.8% | 6,820 | 0.0% | 0.47% | +14.1% |
| Q4 2019 | $1,047,000 | +6.3% | 6,820 | 0.0% | 0.41% | +0.2% |
| Q3 2019 | $985,000 | +1.0% | 6,820 | 0.0% | 0.41% | +0.5% |
| Q2 2019 | $975,000 | +8.3% | 6,820 | 0.0% | 0.41% | +33.0% |
| Q1 2019 | $900,000 | -10.6% | 6,820 | -30.2% | 0.31% | -19.5% |
| Q4 2018 | $1,007,000 | -51.7% | 9,770 | -60.2% | 0.38% | -46.8% |
| Q1 2015 | $2,084,000 | -1.0% | 24,548 | 0.0% | 0.71% | -1.4% |
| Q4 2014 | $2,104,000 | +58.0% | 24,548 | +40.0% | 0.72% | +9.5% |
| Q3 2014 | $1,332,000 | – | 17,529 | – | 0.66% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |